Tenax Therapeutics, Inc.TENXNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank7
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P7
Near historical low
vs 2Y Ago
-2.8x
Contraction
Streak
1 yr
Consecutive growthDecelerating
PeriodValue
2025-141.71%
2024-150.86%
202350.86%
2022-10.62%
2021-17.09%
2020-22.71%
2019-37.27%
201854.66%
201723.49%
2016-61.02%